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Cytokinesis culminates in the final separation, or abscission, of the two daugh-
ter cells at the end of cell division. Abscission relies on an organelle, the
midbody, which forms at the intercellular bridge and is composed of various
proteins arranged in a precise stereotypic pattern. The molecular mechanisms
controlling midbody organization and function, however, are obscure. Here
we show that proper midbody architecture requires cross-regulation between
two cell division kinases, Citron kinase (CIT-K) and Aurora B, the kinase
component of the chromosomal passenger complex (CPC). CIT-K interacts
directlywith three CPC components and is required for propermidbody archi-
tecture and the orderly arrangement of midbody proteins, including the CPC.
In addition, we show that CIT-K promotes Aurora B activity through phos-
phorylation of the INCENP CPC subunit at the TSS motif. In turn, Aurora B
controls CIT-K localization and association with its central spindle partners
through phosphorylation of CIT-K’s coiled coil domain. Our results identify,
for the first time, a cross-regulatory mechanism between two kinases during
cytokinesis, which is crucial for establishing the stereotyped organization of
midbody proteins.1. Introduction
Cytokinesis controls the proper partitioning of cytoplasmic and nuclear
material between the two nascent daughter cells. Defects in this process have
been associated with various human diseases [1] and can cause polyploidy,
which in turn can lead to chromosomal instability, a hallmark of cancer cells
[2]. Cytokinesis progresses through a series of sequential events. First, after ana-
phase onset the mitotic spindle is completely reorganized into an array of
interdigitating and antiparallel microtubules, known as the central spindle
[3]. These microtubules are tightly bundled at their plus ends in a region
known as the spindle midzone. Signals from astral and central spindle microtu-
bules promote the formation of a cleavage furrow at the cell’s equator that
ingresses to bisect the mother cell [4]. Furrow ingression is driven by the assem-
bly and constriction of an actomyosin contractile ring, which progressively
compacts the central spindle to form an organelle known as the midbody.
The midbody provides a platform necessary for the recruitment and organiz-
ation of many proteins that regulate the final abscission of the two daughter
cells [5] and it has also been proposed to contribute to cell fate determination
[6,7], albeit this has not been confirmed in intact organisms [8,9]. The midbody
contains at its centre an electron dense structure known as the ‘midbody matrix’
or ‘midbody ring’ (figure 1). The regions flanking the midbody ring are often
indicated as ‘midbody arms’. Some midbody proteins are former contractile
ring and central spindle components, while others are recruited after com-
pletion of furrow ingression. All these proteins show a very precise and
Figure 1. CIT-K is required for midbody architecture. EM images of midbodies in HeLa Kyoto cells treated with an siRNA directed against either a random sequence
(control) or CIT-K for 48 h. The bottom panels are magnification of the insets as indicated by dotted lines. The arrowhead marks a membrane bleb and the arrows
indicate gaps between the midbody matrix and the cortex. MM, midbody matrix. Scale bars, 1 mm.
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some contractile ring and midzone components, such as
Citron kinase (CIT-K) and the kinesin KIF23/MKLP1,
accumulate at the midbody ring, while other central spindle
proteins, such as the chromosomal passenger complex
(CPC), localize to the midbody arms. This precise distribution
pattern is necessary for midbody assembly and function, but
what controls the architecture of the midbody is unclear. CIT-
K is emerging as an important midbody organizer. This
kinase links a network of contractile ring and central spindle
proteins—including actin, Anillin, myosin, KIF23, KIF14 and
RhoA—in both Drosophila and human cells and has also
recently been shown to be important for the stability
of midbody microtubules in some mouse tissues [11–16].
CIT-K was initially identified as a RhoA effector and
proposed to promote contractile ring constriction through
phosphorylation of the myosin regulatory light chain
(MRLC) [17,18]. However, CIT-K and its Drosophila ortholo-
gue, Sticky (Sti), are not required for furrowing [13,19–22]
and evidence in both Drosophila and human cells has
shown that CIT-K is required for proper RhoA localization
at the cleavage site during late cytokinesis, thus behaving
more like a RhoA regulator than an effector [12,13]. More-
over, Sti is not required for MRLC phosphorylation [12,23].
Together, these findings indicate that CIT-K is not required
for the early stages of cleavage furrow formation and ingres-
sion, but rather for the proper organization and architecture
of the midbody in late cytokinesis. Here we report the charac-
terization of the CIT-K interactome in human cells and
present evidence that this kinase plays a key role in organiz-
ing the proper distribution of midbody components. We also
report that CIT-K binds to three CPC subunits, including its
kinase component Aurora B, both in vivo and in vitro. Further-
more, we show that CIT-K is required for correct CPC
localization and phosphorylates the INCENP subunit of the
CPCat the TSSAurora B activation site. Finally, Aurora B phos-
phorylatesCIT-K to control its localization and interactionwith
central spindle partners. Together, our findings reveal a novel
cross-regulatory mechanism between CIT-K and the CPC
necessary to regulate midbody architecture.2. Results
2.1. CIT-K interacts with the CPC in vivo and in vitro
We previously showed that the midbody matrix appears
scarce, fragmented and disorganized in Drosophila cells after
CIT-K depletion [11]. We observed an almost identical phe-
notype in human HeLa cells after CIT-K depletion. Electron
microscopy (EM) analysis revealed that the midbody matrix
was fragmented, disorganized, detached from the cortex
and mis-positioned towards one of the two nascent daughter
cells (figure 1). Moreover, cortical blebs were often evident
where gaps between the midbody matrix and the membrane
occurred (figure 1, arrowhead). These findings confirmed a
key role for CIT-K in midbody formation in human cells
and prompted us to identify its interactome to understand the
mechanisms that control midbody architecture. We generated
a monoclonal HeLa cell line stably expressing a Flag-tagged
CIT-K transgene that displayed correct localization pattern
and rescued the cytokinesis failure caused by depletion of
endogenous CIT-K, indicating that it is fully functional (elec-
tronic supplementary material, figure S1). By using affinity
purification coupled with mass spectrometry (AP-MS), we
identified 350 proteins that were specifically pulled down
by Flag::CIT-K, but not Flag alone, in HeLa cells synchro-
nized in telophase (figure 2a; electronic supplementary
material, table S1). Among these proteins we found some
expected previously identified partners, such as KIF14 [14]
and the two components of the centralspindlin complex,
KIF23 and RacGAP1 [11], and also other novel interactors,
including three of the four CPC components, Aurora B,
Borealin and INCENP (figure 2b; electronic supplementary
material, table S1). It is very likely that the other CPC com-
ponent, Survivin, was not identified simply because of MS
limitations. The kinesin KIF20A/MKLP2, responsible for
CPC translocation from centromeres to the spindle midzone
[24], was also identified, albeit with a low score (figure 2b;
electronic supplementary material, table S1). Notably, the
microtubule-binding protein PRC1—awell-known direct bind-
ing partner of both KIF14 and KIF23 [11,14,25] but not of CIT-K
(a) (b) (c)
(d)
(e)
( f )
Figure 2. CIT-K associates with the CPC in vivo. (a) Proportional Venn diagram showing the overlap between the proteins pulled down by the Flag tag alone (284)
and the proteins that co-purified with Flag::CIT-K (449). Note that 350 proteins specifically associated with Flag::CIT-K. (b) Partial list of the CIT-K specific interactors
identified by affinity purification. A full list can be found in the electronic supplementary material, table S1, worksheet 1. The bait, CIT-K, is highlighted in red and
previously known CIT-K binding partners are in black. The three subunits of the CPC are in blue and the kinesin responsible for the translocation of the CPC to the
spindle midzone, KIF20A, is in green. (c) HeLa Kyoto cells stably expressing either Flag-tagged CIT-K or Flag alone were synchronized in telophase by thymidine/
nocodazole block and release and then protein extracts were used in a pull-down assay using anti-Flag antibodies. The extracts and pull downs were analysed by
western blot to detect KIF14, KIF23, Aurora B, KIF20A, PRC1 and Flag. Note that a slower migrating KIF23 band was detected in the pull-down compared with whole
cell extracts. This is probably a phosphorylated form that we routinely observe in protein extracts from both telophase cells and purified midbodies. The numbers on
the left indicate the sizes in kilodaltons of the molecular mass marker. (d ) U2OS cells stably expressing Aurora B::Venus were washed in PBS to remove tetracycline
(tet-off inducible system) and kept in tetracycline free media for 24 h. Cells were then fixed and stained to detect CIT-K (red), Aurora B::Venus (green) and tubulin
(blue). Insets show a 3 magnification of the cleavage furrow region. The profiles of the green and red fluorescent signals, measured at the centre of the cleavage
furrow (dotted line), are shown on the right. Scale bar, 10 mm. (e) Midbodies were purified form HeLa Kyoto cells and fixed and stained to detect CIT-K (red) and
tubulin (green). Scale bar, 5 mm. ( f ) Midbodies were purified from HeLa Kyoto cells and fixed and stained to detect CIT-K (green) and Aurora B (red). The
horizontal profiles of the green and red fluorescent signals, measured at the centre of the midbody (dotted lines), are shown on the right. Scale bars, 5 mm.
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analysis preferentially identified proteins strongly associated
with CIT-K. These findings were confirmed by western blot
(figure 2c) and suggested that an interaction between CIT-K
and the CPC might be important for midbody formation.
CIT-K and the CPC both localize to the cleavage furrow
[17,26], but unfortunately we failed to observe localization of
the CPC to the equatorial cortex using antibodies against
Aurora B and INCENP. However, we found that CIT-K co-
localized with Venus-tagged Aurora B at the ingressing
cortex in a transgenic U2OS cell line [27] (figure 2d), albeit
fluorescence intensity profiles indicated that Aurora B-Venus
was distributed closer to the inside edge of the furrow
(figure 2d). CIT-K has been described to localize predominantly
to the cleavage furrow (figure 2d) [17,19], but Flag::CIT-K also
weakly accumulated at the spindle midzone (electronic
supplementary material, figure S1, arrow). This does not
seem to be an over-expression artefact because a similar mid-
zone-associated localization of endogenous CIT-K has already
been reported [28], and we could also observe it in isolated
midbodies (figure 2e and f). This midzone signal partially over-
lapped with the CPC in mid-telophase, but in late-telophaseCIT-K accumulated at the midbody ring, whereas the CPC
localized to the midbody arms (figure 2f).
To assess whether CIT-K could directly bind to the CPC,
we purified recombinant CIT-K fragments tagged with
glutathione S-transferase (GST) from bacteria and tested their
ability to pull down various in vitro translated and radio-
labelled polypeptides of the three CPC subunits identified in
our AP-MS experiments: Aurora B, Borealin and INCENP
(figure 3a–c). All these fragments were chosen on the basis of
the structures of the proteins and their known interaction
domains. We carried out multiple experiments using increas-
ing salt concentrations during the washes in order to have an
indication of the strength of the interactions (figure 3c). The
INCENP central region (residues 262–524) was never pulled
down by any of the GST::CIT-K fragments (figure 3b,c). The
CIT-K CNH domain interacted very strongly with Aurora B,
Borealin and the N-terminal region of INCENP (residues
1–261) (figure 3b,c). A weaker interaction was observed
between the CIT-K kinase domain and the same CPC poly-
peptides that bound to the CNH region (figure 3b,c). Finally,
the CIT-K CC2 region pulled down very well the INCENP
C-terminal region (residues 525–918) and less efficiently
(a)
(b) (c)
(d) (e)
Figure 3. CIT-K directly binds to CPC components in vitro. (a) Schematic diagrams illustrating the protein domains of CIT-K and of the three CPC components
analysed—Aurora B, Borealin and INCENP. The positions of the different CIT-K and INCENP fragments used for the in vitro pull-down assays are also indicated.
Note that CIT-K is not drawn to the same scale as the CPC components. CC1 and CC2 indicate the fragments encompassing the first and second coiled coil regions;
C1, cysteine-rich motif; PH, Pleckstrin homology domain; CNH, Citron-Nik1 homology domain. (b) The GST::CIT-K proteins indicated at the top and GST alone were
incubated with the in vitro translated and radiolabelled Aurora B, Borealin and INCENP polypeptides indicated at the right, and then pulled down using glutathione
beads. The Ponceau S staining of the protein loading is shown at the bottom and the numbers on the left indicate the sizes in kilodaltons of the molecular mass marker.
(c) Summary of the results from the in vitro pull-down assays using GST-CIT-K fragments and in vitro transcribed and translated (IVTT) radiolabelled CPC polypeptides.
The increasing salt concentrations used in the washes are colour-coded and indicated at the top right. The autoradiogram shown in (b) corresponds to the 1 M NaCl
experiment highlighted in blue. (d ) The GST-tagged CPC proteins indicated at the top and GST alone were incubated with the in vitro translated and radiolabelled CIT-K
polypeptides indicated at the right, and then pulled down using glutathione beads. The protein loading is shown at the bottom and the numbers on the left indicate the
sizes in kilodaltons of the molecular mass marker. (e) Ribbon diagram of the predicted structure of the CIT-K C-terminal CNH domain (residues 1634–1948), which
adopts a seven-bladed b-propeller fold. Ribbon is coloured from blue (N-terminus) to red (C-terminus) and the numbers indicate the seven blades.
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pull-down experiments failed to confirm any interaction for
Aurora B, whereas both Borealin and INCENP1–261 could pull
down the CIT-K kinase, CC2 and CNH regions (figure 3d).
INCENP525–918 pulled down the CIT-K kinase and CC2
domains (figure 3d), but the interaction with the CIT-K kinase
domain was never observed in the previous reciprocal assay
(figure 3b,c). We conclude from all these in vitro binding exper-
iments that the CIT-K CNH C-terminal region binds very
strongly to the INCENP N-terminal region, Borealin and poss-
ibly Aurora B. The other two CIT-K regions, kinase and CC2,
showed weaker interactions with the INCENP N-terminal and
C-terminal regions, respectively. Moreover, they also weakly
interacted with Borealin. However, it is difficult to imagine
that all these interactions occur simultaneously and we specu-
late that, in vivo, the association between the CNH domainand the CPC components might be predominant. The exact
function of the CIT-K CNHdomain is unclear, but its predicted
structure of a seven-bladed b-propeller (figure 3e), a structure
known to function as a hub for multiple protein–protein inter-
actions and found in scaffolding proteins of the WD40 family
[29,30], is perfectly consistent with our binding results.2.2. CIT-K is required for proper CPC localization and
the orderly arrangement of midbody proteins
To investigate the functional significance of the interaction
betweenCIT-K and theCPC,we first analysedCPC localization
after CIT-K depletion. The CPC relocates from centromeres to
the spindle midzone after anaphase onset, and then accumu-
lates at the midbody arms [31]. The CPC’s subunit INCENP
(a) (b) (e)
(c) (d)
Figure 4. CIT-K is required for correct CPC localization and the orderly arrangement of midbody proteins. (a) HeLa Kyoto cells were treated with siRNAs directed
against either a random sequence (control) or CIT-K and after 48 h were fixed and stained to detect DNA (blue), tubulin (green) and the CPC component INCENP
(red). The shape and thickness of microtubule bundles at the intercellular bridge were used as criteria to stage telophase cells. Insets show a 3 magnification of
the midbody. Scale bars, 10 mm. (b) Quantification of INCENP localization defects from the experiment shown in (a). More than 100 mid– late-telophase cells were
counted in each experiment, n ¼ 3. Scale bars indicate standard errors. (c) HeLa Kyoto cells stably expressing Flag-tagged wild-type CIT-K, a kinase-dead version
(KD) of CIT-K, or Flag alone were treated with siRNAs directed against either a random sequence (control) or the 30-UTR of CIT-K and after 48 h were fixed and
stained to detect tubulin (blue), Flag (green) and the CPC component INCENP (red). The shape and thickness of microtubule bundles at the intercellular bridge were
used as criteria to stage telophase cells. Insets show a 3 magnification of the midbody. The horizontal profiles of the red fluorescent signals, measured at the
centre of the midbody (dotted lines), are shown at the right of the respective images. Scale bars, 10 mm. (d ) Quantification of INCENP localization defects from the
experiment shown in (c). Only Flag-positive cells were counted, and more than 100 mid– late-telophase cells were counted in each experiment, n ¼ 3. Bars indicate
standard errors. (e) HeLa Kyoto cells were treated with an siRNA directed against either a random sequence (control) or CIT-K and after 48 h were fixed and stained
to detect DNA (blue), Aurora B (green) and KIF23 (red). The shape and thickness of microtubule bundles at the intercellular bridge were used as criteria to stage
telophase cells. Insets show a 3 magnification of the midbody. Scale bars, 10 mm.
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depletion (data not shown), but then failed to form two distinct
bands in about 41% of mid- and late-telophase CIT-K
RNAi cells (figure 4a,b). Often, INCENP appeared mis-
positioned towards one of the two daughter cells (figure 4a),
consistentwith our EManalysis (figure 1). Identical phenotypes
were observed for KIF20A (electronic supplementary material,
figure S2), the kinesin that mediates CPC translocation to the
spindle midzone [24]. Wild-type CIT-K, but not its kinase-dead version (KD-CIT-K), could rescue CPC localization after
depletion of endogenous CIT-K (figure 4c,d), even though the
two transgenic proteins showed identical localization patterns
and were expressed at similar levels (figure 4c, electronic sup-
plementary material, figure S1 and S3). Notably, expression
of KD-CIT-K in control RNAi cells caused an increase of
INCENP abnormal localization (figure 4d), most likely because
of a dominant-negative effect. These results indicate that CIT-K
kinase activity is necessary for proper CPC localization. To
rsob.royalsocietypublishing.org
Open
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architecture, we simultaneously stained CIT-K depleted cells
for Aurora B, whichmarks the midbody arms, and for the kine-
sin KIF23, a well-documented midbody ring/matrix marker
(figure 4e). After CIT-K depletion, KIF23 no longer localized
between the two CPC bands and appeared to be ‘pushed’
towards one side of the midbody in mid-telophase (figure 4e).
In late-telophase CIT-K RNAi cells, KIF23 was often found to
one side of the CPC (figure 4e), even when two Aurora B
bandswere clearlyevident (figure 4e, bottompanels). These phe-
notypes were never observed in control cells. To conclude, our
results indicate thatCIT-K is required forproperCPC localization
and for the orderly arrangement of midbody proteins.Biol.6:1600192.3. CIT-K phosphorylates INCENP at the TSS Aurora B
activation site
To establish whether the components of the CPC could be
CIT-K substrates, we developed an in vitro kinase assay using
the isolated kinase domains (wild-type and kinase dead; KD)
of human and mouse CIT-K purified from bacteria. These
kinase domains were incubated with bacterially purified
GST-tagged Aurora B, Borealin and INCENP. The CIT-K
kinase domain phosphorylated INCENP N- and C-terminal
fragments; however, no clear phosphorylation was observed
for Aurora B and Borealin (electronic supplementary material,
figure S4a and b). To pinpoint which regions of INCENP were
phosphorylated byCIT-K,we repeated the in vitro kinase assay
with smaller GST-tagged INCENP fragments (figure 5a).
CIT-K strongly phosphorylated the INCENP783–918 C-terminal
fragment, which contains the IN-box—responsible for
Aurora B binding and activation [32]—and also weakly the
INCENP64–171 and INCENP262–398 polypeptides (figure 5b).
This phosphorylation pattern was confirmed using bacterially
purified mouse CIT-K, suggesting this phosphorylation is
evolutionarily conserved (electronic supplementary material,
figure S4c and d). MS analysis identified four phosphorylated
residues within the IN-box: T844 and the conserved TSS
Aurora B activation site—T892, S893 and S894 (figure 5a
and electronic supplementary material, S4d ). Substituting the
TSS motif to alanines (TSS/AAA) completely abolished
INCENP783–918 phosphorylation by CIT-K, while there was
only a slight decrease in phosphorylation for the T844A
mutant (figure 5c and electronic supplementary material,
figure S4e). We verified that CIT-K phosphorylated INCENP
in vitro by using an antibody that recognizes the phosphory-
lated TSS motif (pTSS) of human INCENP [33] (figure 5d).
CIT-K depletion in HeLa cells caused a 35% reduction in the
pTSS signal by immunofluorescence (figure 5e). As phos-
phorylation of the TSS motif increases Aurora B kinase
activity [34–36], our data suggested that CIT-K could be
important to elicit full Aurora B activation at the midbody.
Consistent with this hypothesis, CIT-K depletion caused a
significant decrease in Aurora B phosphorylation at T232
(figure 5f), which is essential to achieve full Aurora B activation
following INCENP TSS phosphorylation [35,37]. Notably,
although CPC components often failed to properly localize to
the midbody after CIT-K RNAi, their accumulation was not
reduced (figure 4). Therefore,we conclude thatCIT-K is required
for proper localization and phosphorylation of INCENP and
Aurora B, but not their recruitment, at the midbody.2.4. CIT-K localization during cytokinesis requires Aurora
B activity
We next analysed CIT-K localization after perturbation of CPC
activity. After treatment with the Aurora B inhibitor ZM447439,
CIT-K showed reduced accumulation at the ingressing furrow
in early telophase (figure 6a). Treatment with ZM447439 impairs
the spindle assembly checkpoint and cells exit mitosis very
rapidly, often failing to assemble a proper central spindle and
midbody (figure 6a). Thus, to investigate the role of the CPC in
CIT-K localization in late cytokinesis,weprevented the transloca-
tion of this complex to the spindle midzone by depleting
the kinesin KIF20A [24]. As expected, INCENP failed to accumu-
late at the spindle midzone and persisted at centromeres after
KIF20A depletion (figure 6b,c). Consistent with the results
obtained after Aurora B inhibition (figure 6a), CIT-K showed
reduced accumulation at the cleavage furrow in early telophase
KIF20A RNAi cells (figure 6c). Moreover, CIT-K failed to make
a compact structure at the midbody ring and appeared diffuse
along the cortex in about 47% of late-telophase KIF20A RNAi
cells, a phenotype very rarely observed (1.3%) in control cells
(figure 6c,d ). EM ultrastructural analysis confirmed that, after
KIF20A depletion, themidbodymatrix was scarce, fragmented
and mis-localized, similar to and possibly even slightly
more severe than in CIT-K RNAi cells (figure 6e cf. figure 1).
Moreover, KIF20A depleted cells also showed KIF23 mis-
localization towards one side of the midbody, exactly like
after CIT-K RNAi (figure 6f cf. figure 4e). These results indicate
that CPC recruitment to the midbody is necessary for proper
CIT-K localization and that the CPC and CIT-K cooperate to
organize the architecture of the midbody.
To distinguish whether CIT-K localization required the
whole CPC or just Aurora B activity, we tested if a chimera
composed of the microtubule-binding domain of the spindle
midzone protein PRC1 coupled with an Aurora B kinase
module (dubbed Baronase and comprising a truncated form
of Aurora B and the INCENP activating region) [38] could
rescue CIT-K localization after KIF20A depletion. Cells carry-
ing a doxycycline-inducible PRC1::Baronase transgenic
chimera were depleted of KIF20A and CIT-K localization was
analysed with or without expression of the PRC1::Baronase
chimera. In the absence of transgene expression, cells showed
a frequency of CIT-K abnormal localization very similar
to non-transgenic HeLa cells (figure 6g,h). Induction of
PRC1::Baronase expression, however, considerably rescued
CIT-K localization (figure 6g,h). These results indicate that
CIT-K localization requires primarily Aurora B activity.
2.5. Aurora B phosphorylates CIT-K to regulate its
interaction with central spindle components
As the results described in the previous paragraph indicated
that CIT-K localization depends on Aurora B activity, we next
determined whether Aurora B phosphorylated CIT-K. We
first used MS to analyse the phosphorylation pattern of our
Flag::CIT-K transgene purified from cells synchronized in tel-
ophase. Four out of the twelve identified phosphorylated
sites matched the consensus for Aurora B kinase: S480,
S699, S1385 and S1962 (figure 7a; electronic supplementary
material, table S2). To address if CIT-K could be a direct sub-
strate of Aurora B, we carried out in vitro phosphorylation
assays using recombinant Aurora B and bacterially purified
IM
IC
pTSS/pT232 levels = (IM - IC)
IC
control siRNA
n=35
CIT-K siRNA
n=36
0
0.5
1.0
1.5
2.0
2.5 **
pT
SS
 IN
CE
N
P 
(A
U
)
(a)
M
B
P
G
ST
1-
63
64
-1
71
17
2-
26
1
26
2-
39
8
39
9-
53
4
53
5-
78
2
78
3-
91
8
GST::CIT-K
GST::KD-CIT-K
+
- +
- +
- +
- +
- +
- +
- +
- +
- +
- +
- +
- +
- +
- +
- +
- +
- +
-
GST::INCENP
protein loading
autoradiograph
(b)
(d)
merge pT232 Aurora B tubulin
co
n
tr
ol
 si
RN
A
CI
T-
K
 
siR
N
A
merge pTSS INCENP tubulin
co
n
tr
ol
 si
RN
A
CI
T-
K
 
siR
N
A
(e)
70
55
40
35
25
GST
GST::INCENP783-918
GST::CIT-K
GST::KD-CIT-K
+ + - -
+- ++
+- --
+- --
pTSS INCENP
GST::CIT-K
GST::KD-CIT-K
GST::INCENP783-918
GST
40
G
ST
78
3-
91
8
T8
44
A
TS
S/
A
A
A
T8
44
A
 +
 
TS
S/
A
A
A
GST::CIT-K
GST::KD-CIT-K
+
- +
- +
- +
- +
- +
- +
- +
- +
- +
-
GST::INCENP
(c)
coiled coilCEN1
1
918PVVEI
63
64 171
172
262
261
399
398
534
535 782
783 918
IN-box
T844 T892, S893, S894T343
phosphosites identified by mass spectrometry
*
*
* *
* *
*
*
*
control siRNA
n=25
CIT-K siRNA
n=25
***
0
0.2
0.4
0.8
1.0
1.2
pT
23
2 
A
ur
or
a 
B 
(A
U
)
0.6
INCENP
†70
55
35
25
70
55
35
25
70
55
35
25
100
70
55
35
25
100 protein loading
autoradiograph
*
protein loading
( f )
Figure 5. CIT-K phosphorylates INCENP. (a) Schematic diagram of INCENP structure illustrating the phosphorylated sites identified by MS. The GST-tagged fragments
used for the in vitro phosphorylation assays shown in (b), (c) and (d) are depicted at the bottom. (b) GST-tagged INCENP polypeptides, GST alone, and the positive
control MBP (myelin basic protein) were incubated with GST-tagged CIT-K kinase domain or KD-CIT-K kinase domain in the presence of [g-32P] ATP. The reactions
were then separated by SDS-PAGE, transferred onto nitrocellulose membranes, and exposed at 2808C. The Ponceau S staining of the protein loading is shown at
the bottom. The asterisks mark the molecular positioning of the respective proteins. The dagger (†) indicates CIT-K auto-phosphorylation. The numbers on the left
indicate the sizes in kilodaltons of the molecular mass marker. (c) GST alone, GST-tagged INCENP 783–918 and GST-tagged INCENP mutants (T844A, TSS/AAA and
T844A þ TSS/AAA), were incubated with GST-tagged CIT-K kinase domain or KD-CIT-K kinase domain in the presence of [g-32P] ATP. The reactions were then
separated by SDS-PAGE, transferred onto nitrocellulose membranes, and exposed at 2808C. The protein loading is shown at the bottom. An asterisk marks
CIT-K auto-phosphorylation. The numbers on the left indicate the sizes in kilodaltons of the molecular mass marker. (d ) GST alone and GST-tagged INCENP
783–918 were incubated in the presence or absence of GST-tagged CIT-K kinase domain or KD-CIT-K kinase domain, using non-radioactive ATP. The reactions
were then separated by SDS-PAGE and analysed by western blot to detect phosphorylated INCENP. The protein loading is shown at the bottom. The numbers
on the left indicate the sizes in kilodaltons of the molecular mass marker. (e) HeLa Kyoto cells were treated with siRNAs directed against either a random sequence
(control) or CIT-K for 48 h. During RNAi incubation, cells were synchronized using 2 mM thymidine for 19 h, released for 5 h, treated with 10 mM RO3306 for 13 h,
released for 2 h, fixed and stained to detect phosphorylated INCENP (green), tubulin (red) and DNA (blue). Insets show 2 magnification of the midbody. The box
plot showing the quantification of pTSS fluorescence levels at the midbody is shown on the right. The intensity of pTSS INCENP fluorescence at the midbody was
calculated using the formula shown, where the mean fluorescence intensity was measured at the midbody (IM) and the mean background fluorescence intensity was
measured within an identical area inside the cytoplasm (IC). The numbers of cells counted are detailed below each plot. Scale bars, 10 mm. **p, 0.01 (Student’s
t-test). ( f ) HeLa Kyoto cells were treated as in (e), and stained to detect phosphorylated Aurora B (green), tubulin (red) and DNA (blue). Insets show 2 mag-
nification of the midbody. The box plot showing the quantification of pT232 fluorescence levels at the midbody, calculated as described in (e), is shown on the right.
The numbers of cells counted are detailed below each plot. Scale bars, 10 mm. ***p, 0.001 (Student’s t-test).
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Figure 6. Aurora B activity is necessary for proper CIT-K localization. (a) Asynchronous HeLa Kyoto cells were treated for 20 min with the Aurora B inhibitor
ZM447439 at a final concentration of 5 mM and then fixed and stained to detect CIT-K (red), tubulin (green) and DNA (blue). Scale bars, 10 mm. (b) HeLa
Kyoto cells were treated with siRNAs directed against either a random sequence (control) or KIF20A for 48 h and then proteins were extracted, separated by
SDS-PAGE, transferred to a membrane, and incubated to detect KIF20A and tubulin (loading control). (c) HeLa Kyoto cells were treated with siRNAs directed against
either a random sequence (control) or KIF20A and after 48 h were fixed and stained to detect CIT-K (green), INCENP (red) and tubulin (blue). The shape and
thickness of microtubule bundles at the intercellular bridge were used as criteria to stage telophase cells. Insets show a 3 magnification of the midbody.
Scale bars, 10 mm. (d ) Quantification of CIT-K localization defects from the experiment shown in (c). More than 100 late-telophase cells were counted in
each experiment, n ¼ 3. Bars indicate standard errors. (e) EM images of midbodies from HeLa Kyoto cells treated with an siRNA directed against either a
random sequence (control) or KIF20A for 48 h. The arrowheads mark the midbody matrix (MM) in KIF20A depleted cells. Scale bars, 1 mm. ( f ) HeLa Kyoto
cells were treated with an siRNA directed against either a random sequence (control) or KIF20A and after 48 h were fixed and stained to detect DNA (blue),
tubulin (green) and KIF23 (red). The arrowheads mark the dark zone. Insets show a 3 magnification of the midbody. Scale bars, 10 mm. (g) HeLa Kyoto
cells carrying a doxycycline-inducible GFP-tagged PRC1-Baronase transgene were treated with siRNAs directed against either a random sequence (control) or
KIF20A and after 24 h incubated in 2 mM thymidine for a further 20 h. Cells were washed and incubated with or without 1 mg/ml doxycycline for 10 h and
then fixed and stained to detect CIT-K (red), PRC1-Baronase (green) and tubulin (blue). Scale bars, 10 mm. (h) Quantification of CIT-K localization defects
from the experiments shown in ( f ). More than 100 late-telophase cells were counted in each experiment, n ¼ 3. Bars indicate standard errors.
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regions containing the kinase, CC1 and C1þPH regions
(figure 7b). Consistent with these in vitro results, two residues
found to be phosphorylated in vivo, S480 and S699, lie within
the CC1 region and one, S1385, lies within the C1 domain
(figure 7a). MS analysis confirmed that S699, but not S480,
was phosphorylated by Aurora B in vitro and, consistent with
this, a CC1 fragment containing an S to A mutation at this resi-
due (S699A) was no longer efficiently phosphorylated by
Aurora B in vitro (figure 7c).MS analysis also identified residues
in the C1þ PH region phosphorylated byAurora B in vitro. The
most highly phosphorylated residues were a stretch of two S
and one T residue at positions 1385–1387 and S1474, which
were also found phosphorylated in vivo (figure 7a). However,
only substitution of the residues at positions 1385–1387 into
alanines (TripleA mutant) significantly reduced phosphoryl-
ation by Aurora B in vitro (figure 7d). Together these results
indicate that at least two CIT-K regions are phosphoryla-
ted by Aurora B in vitro and in vivo: S699 and the three SST
residues at 1385–1387. It is, however, possible that other
post-translational modifications and/or factors might be
necessary for Aurora B to recognize and phosphorylate other
CIT-K residues, such as S480 and S1474, in vivo.
As CIT-K interacts with both KIF14 and KIF23 via its CC1
domain [11,15], our results suggested that Aurora B couldregulate the interaction of CIT-K with these two kinesins and
possibly other partners. To address this hypothesis, we gener-
ated a monoclonal cell line expressing a Flag-tagged CIT-K
S699A non-phosphorylatable mutant to test its localization
and interaction with central spindle partners after depletion
of endogenous CIT-K. The S699A mutation enhanced the
association of CIT-K with KIF23 and Aurora B, but only mar-
ginally affected the interaction with KIF14 (figure 7e). Longer
exposures confirmed that Flag-tagged wild-type CIT-K was
also able to bind KIF23 and Aurora B (electronic supple-
mentary material, figure S5), as already shown (figure 2c).
Consistent with this result, the CIT-K S699A mutant showed
strongly increased accumulation at the spindle midzone and
irregular cortical localization in early stages of cytokinesis
(figure 7f,g). Together these findings indicate that CIT-K is an
Aurora B substrate and that Aurora B phosphorylation at
S699 dampens the association of CIT-K with KIF23 and the
CPC in order to reduce CIT-K accumulation at the spindle
midzone in early cytokinesis.3. Discussion
Cross-regulation among mitotic kinases, and in particular
between Aurora B and Polo-like kinase 1 (Plk1), is emerging
(a) (b)
(c) (d) (e)
( f ) (g)
Figure 7. Aurora B phosphorylates CIT-K. (a) Schematic diagram of CIT-K structure illustrating the phosphorylated sites identified by MS. The GST- tagged fragments used for
the in vitro phosphorylation assays shown in (b), (c) and (d) are depicted at the bottom. (b) GST-tagged CIT-K polypeptides, GST alone and the positive control MBP were
incubated with (þ) or without (2) recombinant Aurora B in the presence of [g-32P] ATP. The reactions were then separated by SDS-PAGE, transferred onto nitrocellulose
membranes and exposed at 2808C. The Ponceau S staining of the protein loading is shown at the bottom. Aurora B auto-phosphorylation is marked by an asterisk. The
numbers on the left indicate the sizes in kilodaltons of the molecular mass marker. (c) GST-tagged wild-type CIT-K-CC1 (WT) and S699A mutant polypeptides, GST alone and
the positive control MBP (myelin basic protein) were incubated with (þ) or without (2) recombinant Aurora B in the presence of [g-32P] ATP. The reactions were then
separated by SDS-PAGE, transferred onto nitrocellulose membranes and exposed at2808C. The protein loading is shown at the bottom. Aurora B auto-phosphorylation is
marked by an asterisk. The numbers on the left indicate the sizes in kilodaltons of the molecular mass marker. (d ) The GST-tagged wild-type CIT-K-C1þPH peptide (WT), along
with the S1385A-S1386A-T1387A (TripleA) and S1474A mutant polypeptides, GST alone and the positive control MBP (myelin basic protein) were incubated with (þ) or
without (2) recombinant Aurora B in the presence of [g-32P] ATP. The reactions were then separated by SDS-PAGE, transferred onto nitrocellulose membranes and exposed
at2808C. The protein loading is shown at the bottom. Aurora B auto-phosphorylation is marked by an asterisk. The numbers on the left indicate the sizes in kilodaltons of the
molecular mass marker. (e) HeLa Kyoto cells stably expressing Flag::CIT-K or Flag::CIT-K-S699Awere treated with an siRNA directed against the CIT-K 30-UTR for 48 h, blocked in
metaphase by thymidine/nocodazole block, released for 90 min and then treated with 10mM RO3306 for further 15 min. Proteins were extracted and used in a pull-down
assay with anti-Flag antibodies. The extracts and pull downs were analysed by western blot to detect KIF14, KIF23, Aurora B and Flag::CIT-K. The numbers on the left indicate
the sizes in kilodaltons of the molecular mass marker. (f ) HeLa Kyoto cells stably expressing Flag::CIT-K or Flag::CIT-K-S699A were treated with siRNAs directed against either a
random sequence (control) or 30-UTR CIT-K for 48 h. During RNAi incubation, cells were synchronized using 2 mM thymidine for 19 h, released for 5 h, treated with 10mM
RO3306 for 13 h, released for 2 h, fixed and stained to detect Flag (red), tubulin (green) and DNA (blue). All images are maximum intensity projections of the three most
central z sections; z step¼ 0.25mm. Scale bars, 10 mm. (g) Quantification of CIT-K midzone localization from the experiments showed in (f ). No less than 50 early–mid-
telophase cells were counted in each experiment, n ¼ 4. Bars indicate standard errors.
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Figure 8. Cartoon illustrating the cross-regulation between Aurora B and CIT-K in midbody assembly. The red arrows indicate the phosphorylation of the CIT-K CC1
and C1 domains by Aurora B and the phosphorylation of the INCENP TSS motif by CIT-K. In the presence of CIT-K (a), midbody components including the CPC,
centralspindlin, KIF20A and KIF14 are properly aligned along the midbody. By contrast, after depletion of CIT-K (b) KIF14 is not recruited to the midbody [12,14], the
CPC and KIF20A are dispersed and centralspindlin is mis-positioned on one side of the midbody.
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and to improve fidelity and robustness during cell division
[39–41]. Here we show for the first time that cross-regulation
between two kinases, Aurora B and CIT-K, is crucial for regu-
lation of midbody formation. Our findings identify CIT-K as
a key factor that controls the orderly arrangement of proteins,
including the CPC, at the midbody. These results reinforce
and expand the evidence that CIT-K plays a unique role in
shaping midbody architecture. Our data support a model in
which, thanks to its ability to bind simultaneously to proteins
localized to the midbody ring (i.e. KIF23 and KIF14) and to
the midbody arms (i.e. the CPC), CIT-K could act as both
bridge and organizer (figure 8). However, it is important to
point out that KIF23 and the CPC, albeit improperly loca-
lized, remained separate in the absence of CIT-K (figure 4e).
This indicates that additional mechanisms must exist to
prevent the intermingling of midbody ring and midbody
proteins. We cannot categorically exclude that aberrant local-
ization of midbody proteins could be an indirect effect of the
abnormal midbody structure observed after CIT-K depletion.
However, the evidence that CIT-K directly associates with
these midbody components (this paper and [11]) and that
KIF23 fails to localize to the midbody ‘dark region’ even
when the CPC appears to localize normally (figure 4e),
strongly argue against this possibility.
CIT-K and the CPC display a complex binding pattern
in vitro (figure 3). The very strong interaction observed
between the CIT-K CNH region and all the three CPC sub-
units analysed (figure 3b,c) strongly suggests that this
binding might be prevalent in vivo, and it is tempting to
speculate that different ‘blades’ of the CNH propeller could
interact with distinct components of the CPC. It is note-
worthy that, consistent with these findings, our previous
study in Drosophila indicated that a CIT-K mutant lackingthe CNH domain could not fully rescue cytokinesis failure
after depletion of the endogenous kinase [12]. We cannot
exclude, however, that additional minor interactions between
other CIT-K domains and the CPC could also occur, and
in vivo cross-linking experiments and detailed structural
analyses will be required to define this complex interaction.
Our results indicate that Aurora B phosphorylation con-
trols CIT-K localization and its interaction with spindle
midzone partners through phosphorylation of the CC1
region (figures 4, 6 and 7). This also implies that the interaction
of CIT-K with the CPC is probably not important for CIT-K
localization. Our data indicate that Aurora B phosphorylation
prevents accumulation of CIT-K at the spindle midzone in
early cytokinesis. We speculate that this may act as a timing
mechanism to ensure that CIT-K associates strongly with
KIF23 and the CPC only in late telophase, when CPC activity
diminishes. The localization of CIT-K S669A does not entirely
reflect the distribution of CIT-K after Aurora B inactivation or
CPC removal from the spindle midzone (figure 6). This indi-
cates that Aurora B might control CIT-K localization also via
phosphorylation of other CIT-K regions and/or other cytokin-
esis proteins. Other CIT-K residues phosphorylated in vivo that
match the Aurora B consensus site were found downstream of
the CNH domain and within the C1 region (figure 7a). How-
ever, the CNH region was not phosphorylated by Aurora B
in vitro (figure 7b), indicating either that another kinase is
responsible for this phosphorylation, or that Aurora B might
require other post-translational modifications in order to
recognize this site. By contrast, the C1 region was strongly
phosphorylated in vivo and by Aurora B in vitro (figure 7),
suggesting that the function of this domain is tightly controlled
by Aurora B and possibly other kinases. The role of CIT-K’s C1
domain has not been characterized yet, but it most likely med-
iates the interaction of CIT-K with other proteins and/or
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Although the roles of these phosphorylation events require
further investigation, our results strongly indicate that
Aurora B could regulate multiple CIT-K functions. It is also
worth mentioning that most of the other CIT-K phosphory-
lated sites identified in vivo match the consensus of other
important mitotic kinases, such as Plk1 and Cyclin-dependent
kinases, raising the possibility that multiple signalling path-
ways might converge to regulate the function of this key
regulator of midbody architecture.
CIT-K kinase activity is necessary for proper CPC localiz-
ation and to elicit full activation of Aurora B at the midbody
through phosphorylation of the INCENP TSS motif (figures 4
and 5). As Aurora B phosphorylation in turn controls CIT-K
distribution (figure 7), this data suggests the existence of a
feedback regulatory loop by which CIT-K reinforces both its
own localization and proper architecture of the entire mid-
body (figure 8). Our findings are consistent with previous
results that CIT-K kinase activity is necessary for successful
cytokinesis in Drosophila and human cells [12,15]. INCENP
is the first CIT-K substrate that has been confirmed in vivo.
Previous reports indicating that human CIT-K phosphory-
lated the MRLC [18] were based solely on gain-of-function
experiments and have been challenged by the evidence that
CIT-K depletion did not affect MRLC phosphorylation in
Drosophila cells [12,23]. It will be important in the future to
identify the substrates of this important cytokinetic kinase
to fully understand its functions during cytokinesis.4. Material and methods
4.1. Molecular biology
The cDNA clones for Aurora B, INCENP and Borealin were
kind gifts of Dr C. Lindon (Department of Genetics, University
of Cambridge, UK). Cloning of the full-length open reading
frame (ORF) of human CIT-K was performed by sequentially
inserting three different fragments of theCIT-K cDNAsequence
into the I.M.A.G.E. cDNA clone 4149886 (for simplicity,
renamed construct A) (Source Bioscience). This construct
encodes the 50-terminal region (nt 4–811) of the CIT-K tran-
script (RefSeq accession number: NM_001206999.1) cloned
within the pCMV-SPORT6 vector. First, poly(A) messenger
RNA (mRNA) was extracted from HeLa Kyoto cells using
the MicroPoly(A)Purist Kit (Ambion) and transcribed into
cDNAs using random primers and the SuperScript First-
Strand Synthesis System for RT-PCR (Invitrogen). The resulting
cDNA library was then used as a template to PCR-amplify two
CIT-K fragments dubbed CIT-K kin (nt 267–1385) and CIT-K
mid (nt 1162–4923), using the primers listed in the electronic
supplementary material, table S1 and the Platinum Taq DNA
Polymerase High Fidelity (Invitrogen). These PCR products
were subsequently cloned individually into the pGEM-T Easy
vector using the pGEM-T Easy Vector System (Promega).
Through digestion with the BamHI and NotI restriction
enzymes, the CIT-K kin fragment was excised from the
pGEM-T Easy vector and cloned into construct A in frame
with the upstream 50-terminal CIT-K portion. The CIT-K mid
region was then inserted into the resulting plasmid using the
BglII and NotI restriction sites. Finally, the CIT-K C-terminal
region (CIT-K Ct), spanning nt 4457–6293, was PCR-amplified
from the I.M.A.G.E. cDNA clone 40133624 (Source Bioscience),digested with BstEII and NotI, and ligated to the rest of the
sequence to obtain the full-length human CIT-K ORF. CIT-K
kinase dead (K126A) [43] and S699A mutants were genera-
ted by site-directed mutagenesis using the QuikChange
Lightning Site-Directed Mutagenesis Kit (Agilent) following
manufacturer’s instructions.
For expression of Flag-taggedCIT-Kproteins inHeLaKyoto
cells, aGatewaydestinationvectorwas generated as follows: the
DNA sequence coding for three copies of the Flag epitope and
four copies of the Myc epitope (indicated in the text simply as
Flag), followed by the Gateway cassette for N-terminal fusion,
was PCR-amplified from the pMYFN Gateway destination
vector and then cloned into the pIRESpuro3 vector (Clontech)
using the NheI and EcoRV restriction enzymes.
For bacterial expression of GST-tagged proteins, the
pDEST15 Gateway destination vector (Invitrogen) was used.
All DNA constructs were verified by sequencing.
4.2. Cell culture, siRNA transfection, drug treatments
and generation of stable cell lines
HeLa Kyoto and cells expressing the PRC1::Baronase chimera
were maintained in DMEM (Invitrogen) containing 10% fetal
bovine serum (Sigma) and 1% penicillin/streptomycin (Invitro-
gen) at 378C and 5% CO2. To express the PRC1::Baronase
construct, cells were treated with 1 mg ml21 doxycycline for
10 h.U2OSAurora B::Venus cellswere kept under the same con-
ditions as HeLa Kyoto, with the addition of 1 mg ml21
tetracycline to inhibit expression of Aurora B::Venus (tet-off
inducible system). For RNA interference the following siRNAs
were used: scrambled sequence control, 50-AACGTACGCG
GAATACTTCGA-30; CIT-K, 50-ATGGAAGGCACTATTTCT
CAA-30; CIT-K 30-UTR, 50-CACACUAUGGAACUCUGCU-30;
KIF20A, 50-AACCACCTATGTAATCTCATG-30, using Lipofec-
tamine RNAiMAX (Invitrogen) following the manufacturer’s
instructions.
Cell lines stably expressing Flag alone, Flag::CIT-K,
Flag::KD-CIT-K or Flag::CIT-K-S699A constructs were gener-
ated by plating 2  106 HeLa Kyoto cells in a 100 mm culture
dish and transfected with 19 mg of respective DNA using
FuGENE HD transfection reagent (Promega) for 48 h. Cells
were subsequently washed with PBS and cultured in com-
plete selective medium containing 0.4 mg ml21 puromycin
for approximately two weeks until colonies became visible.
Individual colonies were picked, cultured under resistance
and tested for expression of the construct by western blot
and immunofluorescence.
4.3. Affinity purification
For large-scale affinity purifications of Flag-tagged CIT-K, 4 
107 cells were synchronized in telophase using a thymidine–
nocodazole block and release procedure. They were first
arrested in S phase by the addition of 2 mM thymidine
(Sigma-Aldrich) for 19 h, washed twice with phosphate-buf-
fered saline (PBS) and released for 5 h in fresh complete
medium. After release, cells were cultured for an additional
13 h in fresh complete medium containing 50 ng ml21 nocoda-
zole (Sigma-Aldrich) and then harvested by mitotic shake-off.
Mitotic cells were washed three times with PBS, released in
fresh medium for 1.5 h and incubated for a further 15 min
with the CDK1 inhibitor RO3306 (Calbiochem) at a final
rsob.royalsocietypublishing.org
Open
Biol.6:160019
12
 on April 21, 2017http://rsob.royalsocietypublishing.org/Downloaded from concentration of 10 mM. Cells were then harvested by centrifu-
gation and frozen in liquid nitrogen. The cell pellet was
resuspended in 5 ml of extraction buffer (50 mM HEPES pH
7.5, 100 mM KAc, 150 mM NaCl, 2 mM MgCl2, 1 mM EGTA,
0.5% (v/v) NP-40, 1 mM DTT, 5% (v/v) glycerol and Roche
Complete Protease Inhibitors) and homogenized using a high-
performance disperser (Fisher). The homogenate was clarified
by centrifugation at 750g for 20 min at 48C and the supernatant
was incubated with 200 ml of anti-FLAG M2 Magnetic Beads
(Sigma-Aldrich) for 2–4 h on a rotating wheel at 48C.
Beads were then washed four times in 10 ml of extraction
buffer for 5 min on a rotating wheel, transferred to a new tube
and washed one more time in 10 ml of PBS. Proteins were
eluted from beads with 0.5 M NH4OH and 0.5 mM EDTA,
concentrated, acetone precipitated and analysed by LC-MS/MS.
A very similar procedure was used for western blot ana-
lyses. Ten million cells were resuspended in 3 ml of
extraction buffer and 50 ml of anti-FLAG M2 Magnetic Beads
were added to the supernatant. Washes were performed with
10 ml of extraction buffer. After the last wash in PBS, beads
were resuspended in 2 Laemmli sample buffer (Sigma-
Aldrich), boiled for 10 min and stored at 2208C. Proteins
were separated on an SDS-PAGE gel, transferred onto PVDF
membrane and probed to detect the antigens indicated in the
figure legends.
4.4. Midbody purification
HeLa S3 cells were synchronized in metaphase by thymidine–
nocodazole block as described in the previous section, har-
vested by mitotic shake-off and incubated for an additional
2 h in fresh medium supplemented with 10mM MG132
(Sigma). Cells were thenwashed three timeswith PBS, released
in normal medium and allowed to progress throughout mito-
sis. After approximately 1.5 h, when the vast majority of cells
had completed furrowing, 5 mg ml21 taxol was added to the
medium for 2–3 min to stabilize microtubules in vivo. Cells
were then harvested by centrifugation, washed once with
warm H2O and gently resuspended in a hypotonic swelling
solution containing 1 mM PIPES pH 7, 1 mM MgCl2,
5 mg ml21 taxol (Sigma) and Roche Complete Protease Inhibi-
tors. Cells were immediately centrifuged at 200g for 3 min,
resuspended in lysis buffer (1 mM PIPES pH 7, 1 mM EGTA,
1% (v/v) NP-40, 5 mg ml21 taxol and Roche Complete Pro-
tease Inhibitors) and vortexed vigorously. After the addition
of 0.3 volumes of cold 50 mM 2-(N-morpholino) ethane sulfo-
nic acid (MES) pH 6.3, cells were incubated on ice for 20 min
and then centrifuged at 200g for 10 min at 48C. The supernatant
was transferred to a new tube and centrifuged at 650g for
20 min at 48C to pellet midbodies. The pellet was resuspended
in 50 mM MES pH 6.3 and centrifuged through a cushion of
40% (w/v) glycerol in 50 mM MES pH 6.3 at 2800g for
45 min at 48C. After a final wash in 50 mM MES pH 6.3, mid-
bodies were plated on poly-lysine-coated coverslips and
processed for immunofluorescence as described below.
4.5. Antibodies
The following antibodies were used in this study: mouse
monoclonal anti a-tubulin (clone DM1A, Sigma, T9026),
chicken polyclonal anti-a-tubulin (Abcam, ab89984), mouse
monoclonal anti-Flag (clone M2, Sigma, F3165), mouse mono-
clonal anti-CIT-K (BD Transduction Laboratories, 611377),rabbit polyclonal anti-Aurora B (Abcam, ab2254), rabbit poly-
clonal anti-pT232 Aurora B (Abcam, ab61074), rabbit
polyclonal anti-INCENP (clone P240, Cell Signaling, 2807),
rabbit polyclonal anti-pTSS INCENP (a kind gift of M.A.
Lampson) [33], rabbit polyclonal anti-KIF23 (clone N19,
Santa Cruz Biotechnology, sc-867), rabbit polyclonal anti-
KIF14 (Bethyl Laboratories, A300–233A) and rabbit polyclonal
anti-KIF20A (a kind gift of T.U. Mayer) [44]. Peroxidase and
Alexa-fluor conjugated secondary antibodies were purchased
from Jackson Laboratories and Invitrogen.
4.6. Fluorescence microscopy
HeLa Kyoto cells were grown on microscope glass coverslips
(Menzel-Gla¨ser) and fixed in PHEM buffer (60 mM Pipes,
25 mM HEPES pH 7, 10 mM EGTA, 4 mM MgCl2, 3.7%
(v/v) formaldehyde) for 12 min. They were then washed
three times for 10 min with PBS and incubated in blocking
buffer (PBS, 0.5% (v/v) Triton X-100 and 1% (w/v) BSA)
for 1 h at room temperature (RT). Coverslips were incubated
overnight at 48C with the primary antibodies indicated in the
figure legends, diluted in PBT (PBS, 0.1% (v/v) Triton X-100
and 1% (w/v) BSA). The day after, coverslips were washed
twice for 5 min in PBT, incubated with secondary antibodies
diluted in PBT for 2 h at RT and then washed twice with PBT
and once with PBS. Coverslips were mounted on SuperFrost
Microscope Slides (VWR) using VECTASHIELD Mounting
Medium containing DAPI (Vector Laboratories). Phenotypes
were scored blind and by at least two people independently.
IMAGEJ software was used to generate RGB fluorescence
profiles and intensity values.
4.7. Transmission electron microscopy
For electron microscopy analyses, asynchronous HeLa Kyoto
cells were plated on microscope glass coverslips (Menzel-
Gla¨ser), incubated for 19 h with 2 mM thymidine, washed
three times with PBS, released for 5 h in fresh complete
medium, and incubated for 13 h with 10 mM RO3306. Mitotic
cells were then gently washed with warm PBS, and released
in fresh medium for 2 h. Cells were fixed overnight at 48C in
2.5% (v/v) glutaraldehyde in PBS, post-fixed for 1 h in 1%
(v/v) OsO4 in PBS, dehydrated in a graded series of alcohols,
embedded in Epon-Araldite resin, and polymerized for 2
days at 608C. Glass slides were separated from the resin
after a short immersion in liquid nitrogen. Sections were
obtained with an LKB ultratome, stained with uranyl acetate
and lead citrate, and observed and photographed with an FEI
Tecnai G2 Spirit transmission electron microscope operating
at an accelerating voltage of 100 kV and equipped with a
Morada CCD camera (Olympus).
4.8. In vitro binding assay
DNA fragments coding for CIT-K fragments (kinase, CC1, CC2,
C1þ PH and CNH), Aurora B, Borealin, INCENP1-261 and
INCENP525-918 were generated by PCR and cloned into
pDEST15 (Invitrogen) to express N-terminal GST-tagged poly-
peptides in Escherichia coli. The GST-tagged products were then
purified usingGlutathione Sepharose 4B according tomanufac-
turer’s instruction (GE Healthcare). [35S] Methionine-labelled
Aurora B, Borealin, INCENP (all three fragments) and CIT-K
fragments (kinase, CC2 and CNH) were prepared from
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ing a T7 promoter and then in vitro transcribed and translated
(IVTT) using the TnT T7 Quick Coupled Transcription/Trans-
lation System (Promega) in the presence of [35S] methionine
(PerkinElmer). The binding reaction contained 150 mM NaCl
and subsequent washes varied from 150 mM to 1 M NaCl.
GST pull-down assays were carried out as described [12].
4.9. In vitro phosphorylation assay
GST-tagged CIT-K fragments were incubated with 190 ng of
recombinant human Aurora B (Invitrogen), 0.1 mM ATP
(Sigma-Aldrich), 5 mCi of [g-32P] ATP (6000 Ci mmol21,
10 mCi ml21) (PerkinElmer) and kinase buffer (20 mM
HEPES pH 7.5, 2 mM MgCl2, 1 mM DTT) in a final reaction
volume of 15 ml. After 30 min incubation at 308Cwith constant
agitation, 15 ml of 2 Laemmli sample buffer was added to
stop the reaction. Samples were boiled for 10 min and loaded
on a 4–20% Tris–Glycine precast gel (Thermo Scientific).
Gels were stained with Quick Coomassie Stain (Generon) to
check the protein loading and then proteins were transferred
onto a nitrocellulose membrane using the iBlot Dry Blotting
System (Invitrogen). Membranes were exposed to Kodak
BioMax XAR Films (Sigma-Aldrich) at 2808C. The radioactive
CIT-K in vitro kinase assay was performed as described above
except that GST-tagged CIT-K and KD-CIT-K were incubated
with GST-tagged Aurora B, Borealin and INCENP in a final
volume of 25 ml for 1 h at 308C with constant agitation, where
25 ml of 2 Laemmli sample buffer was added to stop the reac-
tion. The non-radioactive CIT-K in vitro kinase assay was
performed as above except using GST-tagged INCENP 783–
918 as the substrate, with ATP at a final concentration of 0.5 mM.
4.10. Mass spectrometry
For the identification of CIT-K interactors, the raw MS data
were analysed using the MASCOT search engine (http://
www.matrixscience.com). Peptides were searched against the
SWISS-PROT human sequence database and the following
search parameters were employed: enzyme specificity was
set to trypsin, a maximum of two missed cleavages were
allowed, carbamidomethylation (Cys) was set as a fixed modi-
fication, whereas oxidation (Met), phosphorylation (Ser,Thr
and Tyr) and ubiquitylation (Lys) were considered as variable
modifications. Peptide and MS/MS tolerances were set to 25
parts per million (ppm) and 0.8 Da, respectively.
For the identification of phosphorylated residues, beads
with bound proteins were reduced by incubating in 50 mM
Tris(2-carboxyethyl)phosphine hydrochloride for 1 h at
608C, alkylated in 200 mM methyl methanethiosulfonate for
45 min at RT, and then divided into two equal aliquots.
One aliquot was digested overnight with trypsin (sequencing
grade Modified Trypsin—Promega V5111) in standard con-
ditions, while the second aliquot was digested with
protease XIII (Sigma-Aldrich) in 0.1% formic acid at pH 2
for 2 h. We used this second protease because the Aurora B
consensus site contains an arginine (R) or a lysine (K)
upstream of the phosphorylated S or T residues ([R/K]p[S/T]).
Peptide mixtures were then applied to RP-18 precolumns
(nanoACQUITY Symmetryw C18—Waters 186003514) using
water containing 0.1% trifluoroacetic acid as mobile phase
and then transferred to nano-HPLC RP-18 columns(nanoACQUITY BEH C18—Waters 186003545) using an
acetonitrile gradient (5–35%) for 180 min in the presence of
0.05% formic acid with a flow rate of 250 nl min21. Column
outlet was directly coupled to the ion source of the Q
ExactiveTM Hybrid Quadrupole-Orbitrap Mass Spectrometer
(Thermo Electron Corp., San Jose, CA, USA) working in the
regime of data dependent on the MS to MS/MS switch.
A blank run ensuring lack of cross contamination fromprevious
samples preceded each analysis. Acquired raw data were pro-
cessed by Mascot Distiller followed by Mascot Search (Matrix
Science, London, UK) against the SWISS-PROT database
restricted to human sequences. Search parameters for precursor
and product ion mass tolerance were 20 ppm and 0.1 Da,
respectively. For the enzyme specificity we selected either
trypsin with one missed cleavage site allowed, or no-enzyme
specificity for protease XIII digested samples. The following
variable modifications were also selected: cysteine by
methylthio, methionine oxidation, and phosphorylation of
serine, threonine and tyrosine. Peptides with Mascot score
exceeding the threshold value corresponding to less than 5%
false positive rate, calculated by Mascot procedure, and with
the Mascot score above 30 were considered to be positive.
In addition, fragmentation spectra corresponding to the
phosphorylated peptides were manually inspected.4.11. Structure prediction and identification of putative
Aurora B consensus phosphorylation sites
The predicted structure of CIT-K CNH1634–1948 was completed
using the protein homology/analogy recognition engine V 2.0
(Phyre2) [45]. Visualization and analysis was completed using
the molecular modelling software UCSF CHIMERA.
The GPS v. 2.1 software (http://gps.biocuckoo.org)
[46,47] was used to identify consensus sites for Aurora B
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uploaded as part of the electronic supplementary material.
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